International

Donald Trump Latest News: Trump’s $100 Million Kentucky Drug Plant Investment Hinges on November 3 Midterm Elections; President Renews $5,000 Dividend Promise if Republicans Win Congress

Donald Trump Latest News: Trump’s $100 Million Kentucky Drug Plant Investment Hinges on November 3 Midterm Elections; President Renews $5,000 Dividend Promise if Republicans Win Congress
Photo credit: Sunday Guardian

Donald Trump Latest News: US President Donald Trump has announced a proposed $100 million investment in a pharmaceutical manufacturing facility in Winchester, Kentucky, linking the plan to the outcome of the November 3, 2026, midterm elections. Speaking at a rally in Highland Heights, Kentucky, on October 17, Trump said the US Department of War would invest in pharmaceutical company Antheia to help revive the facility.

Trump said the proposed investment would not move forward if Democrats won the midterm elections, making the announcement part of his broader campaign appeal ahead of the vote. He also reiterated a separate promise to provide a $5,000 dividend to every adult US citizen if Republicans retained control of both chambers of Congress. However, details about the proposed payment’s funding and implementation remain unclear.

Trump’s $100 Million Kentucky Pharmaceutical Plant Investment

During his October 17 rally, Trump outlined a proposed $100 million investment in Antheia aimed at reviving a large pharmaceutical manufacturing facility in Winchester, Kentucky. He said the investment would be made through the US Department of War, the name used by his administration for the Department of Defense.

You Might Be Interested In

Trump tied the plan directly to the midterm election outcome, arguing that the project would not proceed under a Democratic electoral victory. According to USA Today, he said Democrats “wouldn’t be able to do it” and “have no idea” how to carry out the project.

The announcement was made publicly at the rally, but the information provided does not establish that the investment has been formally approved or that the funding has been committed. Representatives for the Department of Defense and Republican Representative Andy Barr did not immediately respond to requests for comment, according to the report.

Why the Winchester Drug Manufacturing Facility Matters

Originally published by Sunday Guardian on Oct 18, 2026 Read the full article at sundayguardianlive.com
Read original
About this page. The Ditible is an aggregator. This article was imported from a publisher feed and may have been reformatted. Copyright remains with the original publisher, and the headline, image and any quoted text are used for attribution and indexing purposes. Source links are preserved on every item in the archive.
Share

Comments

0 comments

No comments yet — be the first.

More from Sunday Guardian

View source

Related